![]() |
Back |
|
Neuropharmacology & Analgesia, Immuno-Molecular Pharmacology, Biochemical-Systemic Pharmacology |
|
ORAL PRESENTATIONS/INVITED SPEAKERS/PLENARY LECTURES 1. Salman Khan. Approach toward new drug development based on pharmacological evaluation from naturally isolated compounds. Proceeding of the 47th Annual Meeting of the Korean Society of Pharmacognosy, The 10th KSP-JSP-CJP joint symposium, Ehwa Women University, Seoul, December 22-23, 2018, South Korea 2. Salman Khan. Predominant role of vascular dysfunction and potential of anti-inflammation in alleviation of neuropathic pain. Asia PharmII (The 2nd Asian conference of Pharmaceutical Sciences, Jun 2-22, 2017, Seoul, Korea. 3. Salman Khan, RJ Choi, JH Lee, YS Kim. Attenuation of neuropathic pain and neuroinflammatory responses by a pyranocoumarin derivative, anomalin in animal and cellular models. Proceeding of the 46th Annual Meeting of the Korean Society of Pharmacognosy, Seoul, December 03, 2015, South Korea. 4. Salman Khan, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling and its anti-hyperalgesic effect in an inflammatory pain models. 11th CGCM meeting, August 20~24, 2012, Macau. 5. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, A. Tosun, Y. Shik Kim. Anomalin, pyranocoumarin inhibits LPS-induced expression of inflammatory mediators via NF-κB and MAP-kinase signaling pathways. 10th CGCM meeting August 26~ 28, 2011, Shanghai, China. 6. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. Shik Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin isolated from the root of Saphoshnikovia divaricata in RAW 264.7 macrophages. December 22-24, 2010 (Tokoshima), Japan. 7. Salman Khan, E. M. Shin, D-U. Lee, Y. S. Kim. Bioactivity guided evaluation of sesquiterpenes as an anti-inflammatory activity isolated from Cyperus rotundus L: Effect of chemical structures and cellular signaling pathway. 9th CGCM meeting, 2010. Hong Kong.
POSTER PRESENTATIONS/ CONFERENCES
1. S Khalid, M Ziaullah, A Khan, R Afridi, h Rasheed, A Khan, H Ali, YS Kim, Salman Khan. Antihyperalgesic and antiallodynic properties of honokiol in acute and chronic models of inflammatory pain. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 2. A Khan, M Ziaullah, R Afridi, H Rasheed, S Khalid, H Ullah, YS Kim, Salman Khan. Anti-nociceptive properties of 25-MHA in CFA and carrageenan-induced in animal models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan 3. H Rasheed, R Afridi, A Khan, M Ziaullah, S Khalid, A Atiq, H kashif, MN Ahmad, YS kim, Salman Khan. Anti‑infammatory and analgesic activities of 2‑(5‑me rcapto‑1,3,4‑oxadiazol‑2‑yl)‑N‑propylbenzenesulphonamide (MOPBS) in rodents. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 4. A Atiq, B Shal, M Naveed, A Khan, S Zeeshan, Salman Khan. Pharmacological evaluation of Silver sulfadiazine nanoparticles loaded Alovera encapsulated film on animal mode of wounds. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 5. M Naveed, S Zeeshan, A Khan, B Shal, A Atiq, Salman Khan. Anti-inflammatory, analgesic and antipyretic activities of newly synthesized hetroleptic palladium(II) complexes. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 6. S Zeeshan, M Naveed, A Khan, B Shal, H Rasheed, Salman Khan. Anti-inflamamtory and analgesic effect of novel palladium (II) complexes on animal models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan 7. A Khan, B Shal, M Naveed, A Atiq, S Zeeshan, Salman Khan. Matrine ameliorates anxiety and depressive like behavior in carbon tetrachloride and burn-induced animal models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 8. B Shal, A Khan, M Naveed, A Atiq, S Zeeshan, Salman Khan. Evaluation of pharmacological potential of 25-MHA in LPS and CCl4-induced anxiety and depression models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 9. R Afridi, H Rasheed, A Khan, S Khalid, Z ullah, B Shal, H Jabeen, YS Kim, Salman Khan. Antihyperalgesic properties of Flavone derivative Poncirin in acute and chronic inflammatory pain models in mice. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 10. M Zeeshan, H Ali, M Arshad, MI Khan, M Mukhtar, Salman Khan. Design. Characterization and kinetics study of Glycyrrhizic acid loaded pH-sensitive PLGA nanoparticles for the potential drug targeting in inflammatory bowel disease. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan 11. Salman Khan. 2nd international conference on recent innovations in pharmaceutical sciences (ICRIPS-2017), Organized by Riphah Institute of Pharmaceutical Sciences, November 15-16, 2017, Islamabad, Pakistan. 12. Salman Khan, O. Shehzad, J. Chun, and Y. S. Kim. Mechanism underlying anti-hyperalgesic and anti-allodynic properties of anomalin in both acute and chronic inflammatory pain models in mice through inhibition of NF-κB, CREB and MAPKs signaling cascades. Korean Society of Pharamcognosy 2012. 06. (Seoul, Korea). 13. Salman Khan, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling and its anti-hyperalgesic effect in an inflammatory pain models. 11th CGCM meeting August 20~24, 2012, Macau. 14. Salman Khan, E. M. Shin, S. W. Baek, J. Kim, Y. S. Kim. Novel labdan diterpene derivative isolated from Leonurus japonicum as a function of anti-inflammatory activity in LPS-stimulated RAW 264.7 cells. 9th CGCM meeting, 2010, Hong Kong. 15. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. S. Kim. Anti-inflammatory and anti-NF-κB effects of anomalin isolated from the root of Saposhnikovia divaricata in LPS-stimulated RAW264.7 macrophages. 9th CGCM meeting, 2010, Hong Kong. 16. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. Shik Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin isolated from the root of Saphoshnikovia divaricata in RAW 264.7 macrophages. December 22-24, 2010 (Tokoshima), Japan. 17. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Investigation of flow pattern and volumetric oxygen transfer coefficient (KLa) for new bioreactors equipped with centrifugal impellers. Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jinju S. Korea. 18. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Treatment of Brewery Waste for the Improved Production of Bacterial Cellulose by a Gluconacetobacter Strain, Young Asian Biochemical Engineers’s Community 2007, (YABEC), Japan. 19. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Evaluation of Autolyzed waste of beer fermentation broth as a basal medium for the production of bacterial cellulose and oligosaccharides Gluconacetobacter hansenii, Korean Institute of Chemical Engineers 2007 (KIChE-2007), Daejon, South Korea. 20. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Production and structure feature of bacterial cellulose using nano-bubble system, Young Asian Biochemical Engineers’s Community 2008 (YABEC-2008), Japan. 21. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Production of bacterial cellulose using waste from beer fermentation broth in shaking cultivation, Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jeju do, S.Korea,.
22. O. Shehzad, Salman Khan, T. Khan, J. K. Park, Production of Bacterial Cellulose membrane by G. hasenii using fed batch cultivation. (Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jinju S. Korea.
23. O. Shehzad, Salman Khan, T. Khan, J. K. Park, Production of bacterial cellulose in fed batch cultivation using waste from beer fermentation broth. Korean Institute of Chemical Engineers (KIChE-2008), Pusan, Oct 22, 2008, South Korea.
24. O. Shehzad, Salman Khan, T. Khan, J. K. Park, Physico-Chemico-Mechanical characteristics of bacterial cellulose produced in fed batch cultivation using waste from beer fermentation broth. Korean Institute of Chemical Engineers (KIChE-2008), Pusan, Oct 22, 2008, South Korea.
ii. Courses and Workshops/Trainings
1. 3-days national workshop on “Nanomedicine”: Advancement & Challenges in Pakistan. Organized by HEC-QAU, November 27-29, 2017. 2. “Nanomedicine: Novel Approaches in Drug Delivery”. at Kohat University of Science and Technology, Kohat, Pakistan, 11-12 April 2017. 3. Integrated clinical pharmacy education, practice & Research: Bridging the Gap- Organized by COMSTECH from 22-24 Feb, 2016. 4. 3-days workshop on “Teaching and Research Skills” Organized by HEC-QAU, October 18-20, 2016. |
Salman Khan, Y S Kim. Pharmacological Screening of KFDA samples (natural products) for anti-inflammatory, anti-nociceptive and behavioral pharmacological activities. Joint project between College of Pharmacy, Seoul National University, Seoul, Korea and Department of Pharmacy, QAU. From March 15, 2015~ March 10, 2019), Funded by National Research Foundation (NRF), South Korea. Salman Khan (PI), Gul Majid Khan (Co-PI); “Evaluation of phenolic compounds effect on streptozotocin-induced diabetes and related neuropathic pain model in mice”, 2015-2016 HEC, Pakistan (Rs. 419000) Completed) Salman Khan (Co-PI), Ji Zhang. Potential of anti-inflammation in relieving diabetic neuropathy. Neuroinflammation Training Program, McGill University, Montreal, Quebec, Canada, April 01, 2014~ April 30, 2015. (40000USD) Completed. Salman Khan (PI), YS Kim (Co-PI). BK-21-plus, College of Pharmacy, Seoul National University, Seoul, South Korea, 2013~ 2014 (30000USA) Completed. Salman Khan (PI), Hussain Ali (Co-PI). Therapeutic potential of anti-inflammation in attenuation of neurodegenerative diseases: molecular approach toward specific targets (NRPU-submitted to HEC, Pakistan) Hussain Ali (PI), Salman Khan (Co-PI); “Preparation and characterization of drug loaded PLGA/pH- sensitive PLGA-nanoparticles for therapeutic applications”, HEC, Pakistan (Submitted) |